TWi Biotechnology, Inc. (TPEX:6610)
Taiwan
· Delayed Price · Currency is TWD 36.70
+3.85 (11.72%)
Sep 26, 2025, 2:59 PM CST
TWi Biotechnology Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | - | - | - | - | 66.4 | 1.25 | Upgrade
|
| Revenue Growth (YoY) | - | - | - | - | 5228.81% | -87.11% | Upgrade
|
| Cost of Revenue | - | - | - | - | 0.91 | 1.04 | Upgrade
|
| Gross Profit | - | - | - | - | 65.48 | 0.2 | Upgrade
|
| Selling, General & Admin | 29.32 | 28.35 | 21.15 | 15.62 | 14.12 | 13.77 | Upgrade
|
| Research & Development | 125.06 | 150.14 | 148.41 | 74.56 | 66.66 | 84.99 | Upgrade
|
| Operating Expenses | 154.37 | 178.49 | 169.56 | 90.18 | 80.79 | 98.76 | Upgrade
|
| Operating Income | -154.37 | -178.49 | -169.56 | -90.18 | -15.3 | -98.56 | Upgrade
|
| Interest Expense | -0.13 | -0.16 | -0.09 | -0.05 | -0.09 | -0.02 | Upgrade
|
| Interest & Investment Income | 5.01 | 6.63 | 2.83 | 1.67 | 1.41 | 3.47 | Upgrade
|
| Currency Exchange Gain (Loss) | -7.43 | 7.21 | -4.27 | 12.37 | -1.78 | -6.33 | Upgrade
|
| Other Non Operating Income (Expenses) | 1.65 | 0 | 0.39 | 0 | 0.46 | 0.96 | Upgrade
|
| EBT Excluding Unusual Items | -155.28 | -164.81 | -170.69 | -76.18 | -15.3 | -100.48 | Upgrade
|
| Other Unusual Items | - | - | 0.01 | - | - | -0.03 | Upgrade
|
| Pretax Income | -155.28 | -164.81 | -170.68 | -76.18 | -15.3 | -100.51 | Upgrade
|
| Income Tax Expense | - | - | - | - | - | 1.35 | Upgrade
|
| Net Income | -155.28 | -164.81 | -170.68 | -76.18 | -15.3 | -101.86 | Upgrade
|
| Net Income to Common | -155.28 | -164.81 | -170.68 | -76.18 | -15.3 | -101.86 | Upgrade
|
| Shares Outstanding (Basic) | 88 | 88 | 73 | 67 | 67 | 67 | Upgrade
|
| Shares Outstanding (Diluted) | 88 | 88 | 73 | 67 | 67 | 67 | Upgrade
|
| Shares Change (YoY) | 5.63% | 19.75% | 8.52% | - | - | - | Upgrade
|
| EPS (Basic) | -1.77 | -1.88 | -2.33 | -1.13 | -0.23 | -1.51 | Upgrade
|
| EPS (Diluted) | -1.77 | -1.88 | -2.33 | -1.13 | -0.23 | -1.51 | Upgrade
|
| Free Cash Flow | -131.07 | -155.72 | -134.22 | -60.24 | -34.69 | -62.58 | Upgrade
|
| Free Cash Flow Per Share | -1.49 | -1.78 | -1.83 | -0.89 | -0.51 | -0.93 | Upgrade
|
| Gross Margin | - | - | - | - | 98.63% | 16.29% | Upgrade
|
| Operating Margin | - | - | - | - | -23.04% | -7909.95% | Upgrade
|
| Profit Margin | - | - | - | - | -23.04% | -8174.80% | Upgrade
|
| Free Cash Flow Margin | - | - | - | - | -52.24% | -5022.39% | Upgrade
|
| EBITDA | -147.28 | -171.36 | -162.33 | -82.34 | -6.72 | -89.56 | Upgrade
|
| EBITDA Margin | - | - | - | - | -10.12% | - | Upgrade
|
| D&A For EBITDA | 7.1 | 7.13 | 7.23 | 7.83 | 8.58 | 9 | Upgrade
|
| EBIT | -154.37 | -178.49 | -169.56 | -90.18 | -15.3 | -98.56 | Upgrade
|
| EBIT Margin | - | - | - | - | -23.04% | - | Upgrade
|
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.